drugset / Trial / NCT03678467

Evaluation of EpiBone-CMF for Mandibular Ramus Reconstruction

NCT03678467 ↗

Phase 1/2 Unknown 6 enrolled Epibone, Inc.
NaSingle-groupOpen-labelTreatment

Summary

EpiBone-Craniomaxillofacial (EB-CMF) is an autologous, anatomically shaped bone graft created specifically for the patient's defect, using the patients own adipose-derived mesenchymal stem cells. This first in human trial is designed specifically to assess the safety of EB-CMF clinically. Although secondary measures of graft efficacy are being assessed, the primary focus will be on Adverse Events stemming from graft implantation.

Timeline

Start
2021-03-31
Primary completion
2023-08
Completion
2023-11

Drugs

EvaluationDrugModalityDoseRoute
Subject EB-CMF Unknown — —